(Q41679127)

7 October 2017

1 reference

title

Management of adult patients with ascites caused by cirrhosis (English)

1 reference

7 October 2017

Runyon BA

1

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

7 October 2017

1 reference

7 October 2017

volume

27

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

264-272

1 reference

Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Purpose of quality standards for infectious diseases. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Compensated cirrhosis: Natural history and prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Survival and prognostic indicators in compensated and decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Evaluation of Ascites by Ultrasound

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Care of patients with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

The Serum-Ascites Albumin Gradient Is Superior to the Exudate-Transudate Concept in the Differential Diagnosis of Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites. Another look

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Ascitic fluid analysis in malignancy-related ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Symptoms and investigative findings in 145 patients with tuberculous peritonitis diagnosed by peritoneoscopy and biopsy over a five year period

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Improved method for bacteriological diagnosis of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Spontaneous decrease in portal pressure with clinical improvement in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Electrolyte studies on patients with cirrhosis of the liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Diuresis in the ascitic patient: a randomized controlled trial of three regimens

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Negative influences of ascites on the cardiac function of cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

The effect of large volume paracentesis on plasma volume--a cause of hypovolemia?

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Large-volume paracentesis in nonedematous patients with tense ascites: its effect on intravascular volume

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

ALTERATIONS IN ALBUMIN METABOLISM AFTER SERUM AND ALBUMIN INFUSIONS.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

The effect of repeated albumin infusions in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites. An autopsy study with clinical correlations

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Monomicrobial nonneutrocytic bacterascites: a variant of spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Effect of marked peripheral leukocytosis on the leukocyte count in ascites

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

A rodent model of cirrhosis, ascites, and bacterial peritonitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Selective intestinal decontamination prevents spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Bacterial and fungal infections after liver transplantation: an analysis of 284 patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Infectious sequelae after endoscopic sclerotherapy of oesophageal varices: role of antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510270139

7 January 2021

Identifiers

DOI

10.1002/HEP.510270139

1 reference

7 October 2017

1 reference